OncoSec Medical Inc (ONCS) stock has gained 120.09% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ONCS stock a score of 94 out of a possible 100.
That rank is influenced by a short-term technical score of 99. ONCS's rank also includes a long-term technical score of 97. The fundamental score for ONCS is 86. In addition to the average rating from Wall Street analysts, ONCS stock has a mean target price of 7.666. This means analysts expect the stock to gain 59.05% over the next 12 months.
What's Happening with ONCS Stock Today
OncoSec Medical Inc (ONCS) stock is higher by 13.96% while the S&P 500 has gained 0.52% as of 11:22 AM on Tuesday, Aug 11. ONCS has gained $0.59 from the previous closing price of $4.23 on volume of 1,935,568 shares. Over the past year the S&P 500 has risen 17.16% while ONCS has gained 120.09%. ONCS lost -$2.51 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on OncoSec Medical Inc (ONCS) Stock.
